303 related articles for article (PubMed ID: 29483360)
1. Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.
Rius C; Attaf M; Tungatt K; Bianchi V; Legut M; Bovay A; Donia M; Thor Straten P; Peakman M; Svane IM; Ott S; Connor T; Szomolay B; Dolton G; Sewell AK
J Immunol; 2018 Apr; 200(7):2263-2279. PubMed ID: 29483360
[TBL] [Abstract][Full Text] [Related]
2. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs.
Tungatt K; Bianchi V; Crowther MD; Powell WE; Schauenburg AJ; Trimby A; Donia M; Miles JJ; Holland CJ; Cole DK; Godkin AJ; Peakman M; Straten PT; Svane IM; Sewell AK; Dolton G
J Immunol; 2015 Jan; 194(1):463-74. PubMed ID: 25452566
[TBL] [Abstract][Full Text] [Related]
3. Optimized Peptide-MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells.
Dolton G; Zervoudi E; Rius C; Wall A; Thomas HL; Fuller A; Yeo L; Legut M; Wheeler S; Attaf M; Chudakov DM; Choy E; Peakman M; Sewell AK
Front Immunol; 2018; 9():1378. PubMed ID: 30008714
[TBL] [Abstract][Full Text] [Related]
4. Tricks with tetramers: how to get the most from multimeric peptide-MHC.
Wooldridge L; Lissina A; Cole DK; van den Berg HA; Price DA; Sewell AK
Immunology; 2009 Feb; 126(2):147-64. PubMed ID: 19125886
[TBL] [Abstract][Full Text] [Related]
5. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.
Dolton G; Lissina A; Skowera A; Ladell K; Tungatt K; Jones E; Kronenberg-Versteeg D; Akpovwa H; Pentier JM; Holland CJ; Godkin AJ; Cole DK; Neller MA; Miles JJ; Price DA; Peakman M; Sewell AK
Clin Exp Immunol; 2014 Jul; 177(1):47-63. PubMed ID: 24673376
[TBL] [Abstract][Full Text] [Related]
6. Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.
Rubio-Godoy V; Dutoit V; Rimoldi D; Lienard D; Lejeune F; Speiser D; Guillaume P; Cerottini JC; Romero P; Valmori D
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10302-7. PubMed ID: 11517329
[TBL] [Abstract][Full Text] [Related]
7. HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responses.
van Buuren MM; Dijkgraaf FE; Linnemann C; Toebes M; Chang CX; Mok JY; Nguyen M; van Esch WJ; Kvistborg P; Grotenbreg GM; Schumacher TN
J Immunol; 2014 Jan; 192(2):641-8. PubMed ID: 24342804
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers.
Lissina A; Ladell K; Skowera A; Clement M; Edwards E; Seggewiss R; van den Berg HA; Gostick E; Gallagher K; Jones E; Melenhorst JJ; Godkin AJ; Peakman M; Price DA; Sewell AK; Wooldridge L
J Immunol Methods; 2009 Jan; 340(1):11-24. PubMed ID: 18929568
[TBL] [Abstract][Full Text] [Related]
9. Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
Gannon PO; Wieckowski S; Baumgaertner P; Hebeisen M; Allard M; Speiser DE; Rufer N
J Immunol; 2015 Jul; 195(1):356-66. PubMed ID: 26002978
[TBL] [Abstract][Full Text] [Related]
10. More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.
Dolton G; Tungatt K; Lloyd A; Bianchi V; Theaker SM; Trimby A; Holland CJ; Donia M; Godkin AJ; Cole DK; Straten PT; Peakman M; Svane IM; Sewell AK
Immunology; 2015 Sep; 146(1):11-22. PubMed ID: 26076649
[TBL] [Abstract][Full Text] [Related]
11. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
[TBL] [Abstract][Full Text] [Related]
12. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.
Purbhoo MA; Boulter JM; Price DA; Vuidepot AL; Hourigan CS; Dunbar PR; Olson K; Dawson SJ; Phillips RE; Jakobsen BK; Bell JI; Sewell AK
J Biol Chem; 2001 Aug; 276(35):32786-92. PubMed ID: 11438524
[TBL] [Abstract][Full Text] [Related]
13. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
[TBL] [Abstract][Full Text] [Related]
14. Mixed functional characteristics correlating with TCR-ligand koff -rate of MHC-tetramer reactive T cells within the naive T-cell repertoire.
Hombrink P; Raz Y; Kester MG; de Boer R; Weißbrich B; von dem Borne PA; Busch DH; Schumacher TN; Falkenburg JH; Heemskerk MH
Eur J Immunol; 2013 Nov; 43(11):3038-50. PubMed ID: 23893393
[TBL] [Abstract][Full Text] [Related]
15. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
Yee C; Savage PA; Lee PP; Davis MM; Greenberg PD
J Immunol; 1999 Feb; 162(4):2227-34. PubMed ID: 9973498
[TBL] [Abstract][Full Text] [Related]
16. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes.
Tischer S; Kaireit T; Figueiredo C; Hiller O; Maecker-Kolhoff B; Geyeregger R; Immenschuh S; Blasczyk R; Eiz-Vesper B
Int Immunol; 2012 Sep; 24(9):561-72. PubMed ID: 22740564
[TBL] [Abstract][Full Text] [Related]
17. Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue.
Maeurer MJ; Necker A; Salter RD; Castelli C; Höhn H; Karbach J; Freitag K; Neukirch C; Knuth A; Jäger E
Int J Cancer; 2002 Jan; 97(1):64-71. PubMed ID: 11774245
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers.
Holland CJ; Dolton G; Scurr M; Ladell K; Schauenburg AJ; Miners K; Madura F; Sewell AK; Price DA; Cole DK; Godkin AJ
J Immunol; 2015 Dec; 195(12):5827-36. PubMed ID: 26553072
[TBL] [Abstract][Full Text] [Related]
19. Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
Valmori D; Dutoit V; Liénard D; Rimoldi D; Pittet MJ; Champagne P; Ellefsen K; Sahin U; Speiser D; Lejeune F; Cerottini JC; Romero P
Cancer Res; 2000 Aug; 60(16):4499-506. PubMed ID: 10969798
[TBL] [Abstract][Full Text] [Related]
20. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
